Stem Cell Technologies
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
58
NCT05521438
Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome
Phase: Phase 2/3
Role: Lead Sponsor
Start: Jun 23, 2022
Completion: Dec 31, 2025
NCT05789056
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
Start: Mar 14, 2023
Completion: Dec 30, 2025
NCT06953466
Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Start: Jul 31, 2025
Completion: Jul 30, 2026
Loading map...